References
- Weaver D FM, Camfield P, Fraser A. Massive carbamazepine overdose: clinical and pharmacological observations in five episodes. Neurology 1988; 38: 755–759
- Sullivan J B, Rumack B H, Peterson RG. Acute carbamazepine toxicity resulting from overdose. Neurology 1981; 31: 621–624
- Deng J, Shipe J R, Rogol A D, Donowitz L, Spyker DA. Carbamazepine toxicity: comparison of measurement of drug levels by HPLC and EMIT and model of carbamazepine kinetics. J Toxicol Clin Toxicol 1986; 24: 281–294
- Ritschel WA. Least square fitting. Handbook of Basic Pharmacokinetics Including Clinical Applications, 3rd Edition. Drug Intelligence Publications, Inc., Hamilton, IL 1986; 443–447
- Neuvonen P J, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
- De Zeeuw R A, Westenberg H GM, Van der Kleijn E, Gimbrere J SF. An unusual case of carbamazepine poisoning with a near fatal relapse after two days. J Toxicol Clin Toxicol 1979; 14: 263–269
- Coutselinis A, Poulos L. An unusual case of carbamazepine poisoning with a near fatal relapse after two days. J Toxicol Clin Toxicol 1980; 16: 385–387
- Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinetics 1978; 3: 128–143
- Pond S M, Olsen K R, Osterloh J D, Tong TC. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA 1984; 251: 3104–3108
- Pollack M M, Dunbar B S, Holbrook P R, Fields AI. Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10: 528–529
- Harsch HH. Aspiration of activated charcoal. N Engl J Med 1986; 314: 318